Filing Details

Accession Number:
0001415889-24-027219
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-11-19 16:30:11
Reporting Period:
2024-11-18
Accepted Time:
2024-11-19 16:30:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1082554 United Therapeutics Corp UTHR Pharmaceutical Preparations (2834) 521984749
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1673232 Michael Benkowitz C/O United Therapeutics Corporation
1000 Spring Street
Silver Spring MD 20910
President And Coo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-11-18 7,500 $102.11 7,500 No 4 M Indirect By Trust
Common Stock Disposition 2024-11-18 901 $357.03 6,599 No 4 S Indirect By Trust
Common Stock Disposition 2024-11-18 1,099 $358.00 5,500 No 4 S Indirect By Trust
Common Stock Disposition 2024-11-18 2,921 $359.01 2,579 No 4 S Indirect By Trust
Common Stock Disposition 2024-11-18 1,443 $360.31 1,136 No 4 S Indirect By Trust
Common Stock Disposition 2024-11-18 899 $361.20 237 No 4 S Indirect By Trust
Common Stock Disposition 2024-11-18 237 $362.02 0 No 4 S Indirect By Trust
Common Stock Acquisiton 2024-11-18 2,500 $111.00 2,500 No 4 M Indirect By Trust
Common Stock Disposition 2024-11-18 200 $356.42 2,300 No 4 S Indirect By Trust
Common Stock Disposition 2024-11-18 447 $357.79 1,853 No 4 S Indirect By Trust
Common Stock Disposition 2024-11-18 846 $358.89 1,007 No 4 S Indirect By Trust
Common Stock Disposition 2024-11-18 500 $359.64 507 No 4 S Indirect By Trust
Common Stock Disposition 2024-11-18 307 $360.95 200 No 4 S Indirect By Trust
Common Stock Disposition 2024-11-18 200 $361.86 0 No 4 S Indirect By Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 M Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options Disposition 2024-11-18 7,500 $0.00 7,500 $102.11
Common Stock Stock Options Disposition 2024-11-18 2,500 $0.00 2,500 $111.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
19,500 2017-06-24 2026-06-24 No 4 M Indirect
39,500 2019-03-15 2028-03-15 No 4 M Indirect
Footnotes
  1. This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on August 7, 2024.
  2. Reflects the exercise of options, and sale of the resulting shares ofcommon stock, held in a trust beneficially owned by the ReportingPerson, of which the Reporting Person is a beneficiary, and as to whichthe Reporting Person and his spouse are co-trustees and have sharedinvestment and voting power.
  3. This transaction was executed in multiple trades at prices ranging from $356.50 to $357.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. This transaction was executed in multiple trades at prices ranging from $357.55 to $358.45. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  5. This transaction was executed in multiple trades at prices ranging from $358.59 to $359.52. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  6. This transaction was executed in multiple trades at prices ranging from $359.70 to $360.69. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  7. This transaction was executed in multiple trades at prices ranging from $360.83 to $361.65. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  8. This transaction was executed in multiple trades at prices ranging from $361.88 to $362.19. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  9. Reflects the exercise of options, and sale of the resulting shares ofcommon stock, held in a trust beneficially owned by the Reporting Person,of which the Reporting Person's family members are beneficiaries, and as towhich the Reporting Person has sole investment and voting power.
  10. This transaction was executed in multiple trades at prices ranging from $355.94 to $356.89. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  11. This transaction was executed in multiple trades at prices ranging from $357.28 to $358.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  12. This transaction was executed in multiple trades at prices ranging from $358.36 to $359.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  13. This transaction was executed in multiple trades at prices ranging from $359.40 to $359.98. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  14. This transaction was executed in multiple trades at prices ranging from $360.47 to $361.37. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  15. This transaction was executed in multiple trades at prices ranging from $361.65 to $362.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.